Eccogene Announces First Patient Enrolled in MOSAIC Phase 2a Trial Evaluating ECC4703 and ECC0509, Individually and in Combination, for the Treatment of MASH [Yahoo! Finance]
Mosaic Company (The) (MOS)
Last mosaic company (the) earnings: 2/19 04:42 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.mosaicco.com
Company Research
Source: Yahoo! Finance
molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced that the first patient has been enrolled in MOSAIC, the company's Phase 2a clinical trial evaluating ECC4703, ECC0509 and their combination in adults with MRI-based or clinically defined metabolic dysfunction-associated steatohepatitis (MASH). The MOSAIC trial is designed to evaluate two differentiated mechanisms, THR-ß agonism and SSAO inhibition, and to determine whether each monotherapy provides meaningful metabolic or inflammatory benefit. "Enrolling the first patient in MOSAIC represents an important milestone for our clinical pipeline," said Jingye Zhou, Chief Executive Officer of Eccogene. "This study supports our broader strategy to advance differentiated, next-generation oral therapies aimed at meaningfully reducing the global burden of cardiometabolic diseases." The initiation of the MOSAIC Phase 2a program follows the U.S. FDA clearance of Eccogene's Investigational New Drug (
Show less
Read more
Impact Snapshot
Event Time:
MOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MOS alerts
High impacting Mosaic Company (The) news events
Weekly update
A roundup of the hottest topics
MOS
News
- Worker dies at underground potash mine in southern Saskatchewan [Yahoo! Finance Canada]Yahoo! Finance Canada
- Mosaic (MOS) Climbs 4% on Bargain-Hunting [Yahoo! Finance]Yahoo! Finance
- Mosaic (MOS) Gets Price Target Cut as RBC Assesses 2026 Fertilizer Trends [Yahoo! Finance]Yahoo! Finance
- Mosaic (NYSE:MOS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Mosaic (NYSE:MOS) was given a new $27.00 price target on by analysts at Royal Bank Of Canada.MarketBeat
MOS
Earnings
- 11/4/25 - Beat
MOS
Sec Filings
- 11/12/25 - Form 424B5
- 11/10/25 - Form FWP
- 11/10/25 - Form 424B5
- MOS's page on the SEC website